Weekly Digest - April 2025
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
CAR-T Digest - August 2020
Weekly Digest - April 2025
07 Apr 2025: Novelty Nobility, selected by JLABS Korea, hosted by Johnson & Johnson
- Novelty Nobility has joined JLABS Korea, Johnson & Johnson’s global incubator network, to accelerate its antibody drug development efforts
- The company will focus its JLABS participation on advancing NN4101, a dual antibody for vascular retinal diseases, and NN3206, an ADC targeting Pan-RAS mutant solid tumors
- By leveraging JLABS’ global expertise and network, Novelty Nobility aims to enhance its early-stage pipeline’s competitiveness in international markets
- The company specializes in next-generation antibody therapeutics, including dual antibodies and ADCs, based on its own fully human antibody platform
